IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Pharmaceutical Products Manufacturing industry in Mexico includes market sizing, forecasting, data and analysis from 2009-2024. The most recent publication was released April 2019.
The Pharmaceutical Products Manufacturing industry in Mexico operates under the NAICS industry code 32541MX. Over the five years to 2019, revenue for the Pharmaceutical Products Manufacturing industry in Mexico has grown marginally. The industry comprises establishments that manufacture pharmaceutical preparations and companies that produce raw materials used in the pharmaceutical product manufacturing process. Disposable medical material manufacturers are not included in this industry. IBISWorld estimates that industry revenue has grown an annualized 0.2% to MXN $203.3 billion over the five years to 2019. During the period, the industry has benefited from an aging population, a decline in mortality, growing consumer spending and increased accessibility to medications. Growth in nominal terms has been largely offset by growth in inflation during the period, which has significantly tempered revenue growth in real terms. Related terms covered in the Pharmaceutical Products Manufacturing industry in Mexico include biologic, cofepris and over-the-counter (otc) drugs.
Products and services covered in Pharmaceutical Products Manufacturing industry in Mexico include Production of active ingredients and other primary products, Production of medications for human use and Production of medications for veterinary use.
Companies covered in the Pharmaceutical Products Manufacturing industry in Mexico include Bayer AG, Pfizer Inc. and Laboratorios de Sanfer SA de CV.
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Pharmaceutical Products Manufacturing industry in Mexico.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
The Products and Markets chapter covers detailed products and service segmentation and analysis of major markets for the for the Pharmaceutical Products Manufacturing industry in Mexico.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Pharmaceutical Products Manufacturing industry in Mexico.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Pharmaceutical Products Manufacturing industry in Mexico. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
The Companies chapter covers Key Takeaways, Market Share and Companies in the Pharmaceutical Products Manufacturing industry in Mexico. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Pharmaceutical Products Manufacturing industry in Mexico. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Pharmaceutical Products Manufacturing industry in Mexico. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Pharmaceutical Products Manufacturing industry in Mexico.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The market size of the Pharmaceutical Products Manufacturing industry in Mexico is $203.3bn in 2019.
There are 490 businesses in the Pharmaceutical Products Manufacturing industry in Mexico, which has declined at a CAGR of -0.9% between 2014 and 2019.
The market size of the Pharmaceutical Products Manufacturing industry in Mexico has been at a CAGR of 0.2% between 2014 and 2019.
The Pharmaceutical Products Manufacturing in Mexico market is forecast to over the five years from 2019 to 2024
The biggest companies operating in the Pharmaceutical Products Manufacturing market in Mexico are Bayer AG, Pfizer Inc. and Laboratorios de Sanfer SA de CV
Manufacturing raw materials used in to produce pharmaceutical preparations and Manufacturing pharmaceutical preparations are part of the Pharmaceutical Products Manufacturing industry.
The company holding the most market share in Mexico is Bayer AG.
There are 80,630 employed in the Pharmaceutical Products Manufacturing industry in Mexico 2019.